Alexandra Rizzitelli

Alexandra Rizzitelli's work experience includes various roles in the pharmaceutical and medical research fields. Alexandra is currently serving as the Head of Scientific Affairs at CLINUVEL PHARMACEUTICALS LTD since October 2022. Prior to this, they worked as a Consultant for Cell and Gene Therapy at potentCELLS starting from August 2022. In 2022, they also held the position of Senior Program Manager (Biologics) at Patheon from February to July.

From 2015 to 2022, Alexandra worked at Cell Therapies Pty Ltd, where they had multiple roles. Alexandra started as the Transplant Laboratory Services Manager from March 2020 to February 2022. Additionally, they served as a Cell Therapy Specialist (Cell and Gene Therapies) from June 2015 to February 2022, overseeing the manufacturing of human cell therapies for phase I / II clinical trials and managing hospital clinical services.

Before their time at Cell Therapies Pty Ltd, Alexandra worked as a Clinical Research Coordinator at Peninsula Health from February 2014 to May 2015. In this role, they wrote and managed applications for clinical trials, collected and analyzed trial data, and reported adverse effects.

Alexandra's earlier experiences include working as a Laboratory Operations Manager at Peter MacCallum Cancer Centre from March 2012 to February 2014. Alexandra also served as a Research Officer at Monash University from January 2008 to February 2012, where they conducted independent investigations on the immune system and secured grant funding. Prior to that, they worked as a Research Officer at the Walter and Eliza Hall Institute of Medical Research from October 2002 to December 2006, focusing on immunological research.

Alexandra Rizzitelli completed their Ph.D. at CEA in 1999.

Alexandra Rizzitelli obtained their Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from Universite Joseph Fourier in Grenoble, France. Alexandra completed their doctoral studies from 1999 to 2002.

In terms of additional certifications, Alexandra obtained the following:

1. QMS primer from SeerPharma in February 2023.

2. Introduction to Drug Safety and Pharmacovigilance from Biopharma Institute in September 2022.

3. Leading Edge Program from Women & Leadership Australia (WLA) in November 2019.

4. Design and Interpretation of Clinical Trials from Coursera in May 2015.

5. Data Management for Clinical Research from Coursera in December 2014.

Overall, Alexandra Rizzitelli's educational background includes a Ph.D. in Cell/Cellular and Molecular Biology and various certifications related to clinical trials, drug safety, leadership, and data management in clinical research.